Phase I, Dose-Escalation Study of 2 Dosing Regimens of AS703569, An Inhibitor of Aurora and Other Kinases, Administered Orally in Patients with Advanced Hematological Malignancies

Sonet, Anne;Graux, Carlos;Maertens, Johan;Hartog, Christine-Maria;Ottmann, Oliver;et.al.
(2008) 50th Annual Meeting of the American- Society-of-Hematology — Location: San Francisco(Ca) (6.December.2008)

Files

No attached file found for this publication.

Details

Authors
  • Sonet, AnneMONT
    Author
  • Graux, CarlosUCLouvain
    Author
  • Maertens, JohanUCLouvain
    Author
  • Hartog, Christine-Maria
    Author
  • Ottmann, Oliver
    Author
Show more
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Sonet, A., Graux, C., Maertens, J., Hartog, C.-M., Duyster, J., Goetze, K., Greiner, J., Huetter, M.-L., Gratwohl, A., Heim, D., Hess, D., Chalandon, Y., Gianella-Borradori, A., Rejeb, N., & Ottmann, O. (2008). Phase I, Dose-Escalation Study of 2 Dosing Regimens of AS703569, An Inhibitor of Aurora and Other Kinases, Administered Orally in Patients with Advanced Hematological Malignancies. Blood, 112(11), 1018. https://hdl.handle.net/2078.5/147642 (Original work published 2008)